Leading 25 corporate institutions

The leading 25 corporate institutions ranked by total article Share (Share) in cancer research from 2018 to 2022. Also listed are each institution's total cancer article count (Count) and proportion of cancer Share relative to total Share (Cancer %) over the same period.

Click on column headers to sort

Rank	Institution	Location	Share 2018–22	Count 2018–22	Cancer (%)
1	F. Hoffmann-La Roche AG	Switzerland	101.74	246	38.7%
2	Novartis International AG	Switzerland	38.84	158	28.3%
3	AstraZeneca plc	United Kingdom (UK)	38.45	183	25.2%
4	Pfizer Inc.	United States of America (USA)	21.20	60	22.8%
5	Bristol-Myers Squibb (BMS)	United States of America (USA)	18.35	78	23.5%
6	Leidos Holdings, Inc.	United States of America (USA)	17.76	200	52.1%
7	Merck & Co., Inc.	United States of America (USA)	17.02	59	11.1%
8	GlaxoSmithKline plc. (GSK)	United Kingdom (UK)	13.00	76	17.8%
9	Takeda Pharmaceutical Company Limited	Japan	12.02	31	43.9%
10	Amgen Inc.	United States of America (USA)	11.25	50	18.3%
11	Regeneron Pharmaceuticals, Inc.	United States of America (USA)	10.54	22	20.6%
12	Formosa Plastics Group	Taiwan	10.37	42	25.7%
13	AbbVie Inc.	United States of America (USA)	8.77	44	21.1%
14	Eisai Co., Ltd.	Japan	8.47	24	77.8%
15	Techint Group	Italy	7.95	44	53.2%
16	Alphabet Inc.	United States of America (USA)	7.94	20	6.0%
17	C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim)	Germany	7.92	32	26.3%
18	Sanofi	France	7.82	28	19.9%
19	BGI	China	6.66	37	13.7%
20	NanoString Technologies, Inc.	United States of America (USA)	6.42	22	85.5%
21	Johnson & Johnson	United States of America (USA)	6.23	43	10.1%
22	Samsung Group	South Korea	5.46	68	7.4%
23	Foundation Medicine, Inc.	United States of America (USA)	5.39	40	100.0%
24	Bayer AG	Germany	5.29	39	20.8%
25	BioNTech AG	Germany	4.61	12	49.5%